BNT162b2 vaccine effectiveness was marginally affected by the SARS-CoV-2 beta variant in fully vaccinated individuals

OBJECTIVE: To evaluate the effectiveness of the Pfizer BNT162b2 vaccine against the SARS-Cov-2 Beta variant. STUDY DESIGN AND SETTING: Israel's mass vaccination program, using two doses of the Pfizer BNT162b2 vaccine, successfully curtailed the Alpha variant outbreak during winter 2020–2021, Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Mor, Orna, Zuckerman, Neta S., Hazan, Itay, Fluss, Ronen, Ash, Nachman, Ginish, Netanel, Mendelson, Ella, Alroy-Preis, Sharon, Freedman, Laurence, Huppert, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553421/
https://www.ncbi.nlm.nih.gov/pubmed/34715314
http://dx.doi.org/10.1016/j.jclinepi.2021.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553421/
https://www.ncbi.nlm.nih.gov/pubmed/34715314
http://dx.doi.org/10.1016/j.jclinepi.2021.10.011

Ejemplares similares